Related Experiment Video

Updated: Jun 12, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Atherosclerosis in patients with cyanotic congenital heart disease

Mariëlle G J Duffels1, Karlijn M Mulder, Mieke D Trip

  • 1Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands.

Circulation Journal : Official Journal of the Japanese Circulation Society
|June 8, 2010
PubMed

Insights

Adults with cyanotic congenital heart disease (CHD) show reduced atherosclerosis, indicated by decreased carotid intima-media thickness (IMT). This may stem from lower cholesterol, blood pressure, and platelet levels, alongside higher bilirubin.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Metabolic Syndrome

Background:

  • Cyanotic congenital heart disease (CHD) may confer protection against atherosclerosis.
  • Understanding this potential protective effect is crucial for managing cardiovascular risk in these patients.

Purpose of the Study:

  • To investigate atherosclerotic risk factors and carotid intima-media thickness (IMT) in adults with cyanotic CHD.
  • To compare these parameters with age- and sex-matched healthy controls.

Main Methods:

  • Cross-sectional study involving 54 adults with cyanotic CHD (mean age 38 years, 81% saturation) and 54 controls.
  • Carotid intima-media thickness (IMT) and various risk factors (cholesterol, thrombocytes, bilirubin, blood pressure) were measured and compared between groups.

Main Results:

  • Cyanotic CHD patients exhibited significantly decreased mean carotid IMT compared to controls (adjusted for age).
  • Patients had lower total cholesterol, lower thrombocyte counts, higher bilirubin levels, and lower systolic and diastolic blood pressure than controls.

Conclusions:

  • Patients with cyanotic CHD demonstrate reduced carotid IMT, suggesting a lower risk of atherosclerosis.
  • This protective effect may be attributed to a combination of favorable risk factor profiles, including lower blood pressure, cholesterol, and thrombocyte levels, and higher bilirubin levels.
Abstract

More Related Videos

Intra-cardiac Side-Firing Light Catheter for Monitoring Cellular Metabolism using Transmural Absorbance Spectroscopy of Perfused Mammalian Hearts08:51

Intra-cardiac Side-Firing Light Catheter for Monitoring Cellular Metabolism using Transmural Absorbance Spectroscopy of Perfused Mammalian Hearts

Published on: May 12, 2019

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery (ALCAPA)13:10

Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery (ALCAPA)

Published on: April 24, 2017

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...